US Patent Issued to Coriolis Pharma Research on Sept. 1 for "FIM-CNN for detection of viable cells and/or particulate impurities" (German Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,725,435, issued on Sept. 1, was assigned to Coriolis Pharma Research GmbH (Martinsried, Germany).

"FIM-CNN for detection of viable cells and/or particulate impurities" was invented by Andrea Hawe (Martinsried, Germany), Tim Menzen (Martinsried, Germany), Adam Grabarek (Martinsried, Germany) and Alexandra Roesch (Martinsried, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure presented herein provides methods for quantifying viable cells and particulate cell impurities in a cell-based product sample. The method is implemented on a convolutional neural network (CNN) that learns to classify flow-imaging microscopy (FIM) images. The CNN l...